Volume 40 Issue 6
Nov.  2019
Turn off MathJax
Article Contents

James Mwangi, Xue Hao, Ren Lai, Zhi-Ye Zhang. Antimicrobial peptides: new hope in the war against multidrug resistance. Zoological Research, 2019, 40(6): 488-505. doi: 10.24272/j.issn.2095-8137.2019.062
Citation: James Mwangi, Xue Hao, Ren Lai, Zhi-Ye Zhang. Antimicrobial peptides: new hope in the war against multidrug resistance. Zoological Research, 2019, 40(6): 488-505. doi: 10.24272/j.issn.2095-8137.2019.062

Antimicrobial peptides: new hope in the war against multidrug resistance

doi: 10.24272/j.issn.2095-8137.2019.062
Funds:  the National Natural Science Foundation of China(21761142002 and 31801975);Chinese Academy of Sciences(XDB31000000);Yunnan Province Grant(2015HA023)
More Information
  • Corresponding author: Zhi-Ye Zhang
  • Received Date: 2019-07-23
  • Accepted Date: 2019-09-26
  • Publish Date: 2019-10-14
  • The discovery of antibiotics marked a golden age in the revolution of human medicine. However, decades later, bacterial infections remain a global healthcare threat, and a return to the pre-antibiotic era seems inevitable if stringent measures are not adopted to curb the rapid emergence and spread of multidrug resistance and the indiscriminate use of antibiotics. In hospital settings, multidrug resistant (MDR) pathogens, including carbapenem-resistant Pseudomonas aeruginosa, vancomycin-resistant enterococci (VRE), methicillin-resistant Staphylococcus aureus (MRSA), and extended-spectrum β-lactamases (ESBL) bearing Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae are amongst the most problematic due to the paucity of treatment options, increased hospital stay, and exorbitant medical costs. Antimicrobial peptides (AMPs) provide an excellent potential strategy for combating these threats. Compared to empirical antibiotics, they show low tendency to select for resistance, rapid killing action, broad-spectrum activity, and extraordinary clinical efficacy against several MDR strains. Therefore, this review highlights multidrug resistance among nosocomial bacterial pathogens and its implications and reiterates the importance of AMPs as next-generation antibiotics for combating MDR superbugs.
  • 加载中
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(2534) PDF downloads(1428) Cited by()

Related
Proportional views

Antimicrobial peptides: new hope in the war against multidrug resistance

doi: 10.24272/j.issn.2095-8137.2019.062
Funds:  the National Natural Science Foundation of China(21761142002 and 31801975);Chinese Academy of Sciences(XDB31000000);Yunnan Province Grant(2015HA023)
    Corresponding author: Zhi-Ye Zhang

Abstract: The discovery of antibiotics marked a golden age in the revolution of human medicine. However, decades later, bacterial infections remain a global healthcare threat, and a return to the pre-antibiotic era seems inevitable if stringent measures are not adopted to curb the rapid emergence and spread of multidrug resistance and the indiscriminate use of antibiotics. In hospital settings, multidrug resistant (MDR) pathogens, including carbapenem-resistant Pseudomonas aeruginosa, vancomycin-resistant enterococci (VRE), methicillin-resistant Staphylococcus aureus (MRSA), and extended-spectrum β-lactamases (ESBL) bearing Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae are amongst the most problematic due to the paucity of treatment options, increased hospital stay, and exorbitant medical costs. Antimicrobial peptides (AMPs) provide an excellent potential strategy for combating these threats. Compared to empirical antibiotics, they show low tendency to select for resistance, rapid killing action, broad-spectrum activity, and extraordinary clinical efficacy against several MDR strains. Therefore, this review highlights multidrug resistance among nosocomial bacterial pathogens and its implications and reiterates the importance of AMPs as next-generation antibiotics for combating MDR superbugs.

James Mwangi, Xue Hao, Ren Lai, Zhi-Ye Zhang. Antimicrobial peptides: new hope in the war against multidrug resistance. Zoological Research, 2019, 40(6): 488-505. doi: 10.24272/j.issn.2095-8137.2019.062
Citation: James Mwangi, Xue Hao, Ren Lai, Zhi-Ye Zhang. Antimicrobial peptides: new hope in the war against multidrug resistance. Zoological Research, 2019, 40(6): 488-505. doi: 10.24272/j.issn.2095-8137.2019.062

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return